°øÁö»çÇ×

HOME > ÇÐȸ¼Ò°³   >   °øÁö»çÇ×

[4¿ù 16ÀÏ] ¼ºÀÎALL ¿¬±¸È¸ ½ÉÆ÷Áö¾ö
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
ÀÛ¼ºÀÏ
2022-04-08
Á¶È¸
2226

2022 ¼ºÀα޼º¸²ÇÁ¸ð±¸¹éÇ÷º´ ¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö

 

    

¾È³çÇϽʴϱî?

    

´Ù°¡¿À´Â 4¿ù 16ÀÏ Åä¿äÀÏ, ºÎ»ê º¤½ºÄÚ¿¡¼­ 2022¼ºÀα޼º¸²ÇÁ¸ð±¸¹éÇ÷º´ Ãá°è½ÉÆ÷Áö¾öÀÌ °³ÃÖµÉ ¿¹Á¤ÀÔ´Ï´Ù.

À̹ø ½ÉÆ÷Áö¾ö¿¡¼­´Â 2021³â ÁøÇàµÇ¾ú´ø ASH annual meeting ¿¡¼­ update µÈ ³»¿ëµéÀ» Á¤¸®ÇÏ°í,

ÃÖ±Ù ALL °ü·Ã Hot topic ÀÎ MRD ¿Í T-cell engineering ¿¡ ´ëÇÑ ³»¿ëµéÀ» ´Ù·ç°íÀÚ ÇÕ´Ï´Ù.

¶ÇÇÑ, ±Ý³â ½ÉÆ÷Áö¾öºÎÅÍ´Â ALL °ú °ü·ÃµÈ ´Ù±â°ü Àӻ󿬱¸¸¦ È°¼ºÈ­ ½ÃÅ°°íÀÚ »õ·Î¿î ¿¬±¸ Á¦¾ÈÀ» ¹Þ°íÀÚ ÇÕ´Ï´Ù.

ÀüÇ⿬±¸, ÈÄÇ⿬±¸ »ó°ü¾øÀÌ ÁÁÀº ¾ÆÀ̵ð¾î°¡ ÀÖÀ¸½Å ºÐµéÀ» ºÎ´ã¾øÀÌ ¾Æ·¡ ¸ÞÀÏ·Î ÀÇ°ßÁÖ½Ã¸é °¨»çÇÏ°Ú½À´Ï´Ù

½ÉÆ÷Áö¾ö °ü·Ã ÀÚ¼¼ÇÑ ³»¿ëÀº ¾Æ·¡ ÀÏÁ¤Ç¥¸¦ Âü°íÇØÁÖ½Ã°í ¿¬ÀÚ°¡ È®Á¤µÇ´Â ´ë·Î Ãß°¡ ¾È³»µå¸®µµ·Ï ÇÏ°Ú½À´Ï´Ù.

Âü¼®À» ¿øÇϽô ºÐµé²²¼­´Â ¾Æ·¡ »çÀüµî·Ï ¸µÅ©¸¦ ÀÌ¿ëÇØ µî·Ï ºÎŹµå¸³´Ï´Ù. °¨»çÇÕ´Ï´Ù.   

    

¼ºÀα޼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸ À§¿øÀå ½ÅÈ£Áø/°£»ç ±è´ë½Ä  

 

 

‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒

 

 

ÀϽÃ: 2022³â 4¿ù 16ÀÏ (Åä) 10:00 – 16:00

Àå¼Ò: ºÎ»ê, º¤½ºÄÚ Á¦1ȸÀÇÀå 214È£-218È£

¿¬¼ö ÆòÁ¡: ´ëÇÑÀÇ»çÇùȸ 4ÆòÁ¡, ´ëÇѳ»°úÇÐȸ Ç÷¾×Á¾¾ç³»°ú ºÐ°úÀü¹®ÀÇ 4ÆòÁ¡

µî·Ïºñ: ¹«·á (¼÷¹Ú Áö¿ø)

¼÷¹Ú: ¼¾ÅÒÇÁ¸®¹Ì¾î È£ÅÚ (15ÀÏ, ±Ý¿äÀÏ 1¹Ú Áö¿ø)

»çÀüµî·Ï ¸¶°¨: 2022³â 4¿ù 9ÀÏ

 

Session 1: Update on ALL 2022 (°æºÏÀÇ´ë ¹®ÁØÈ£)

10:00-10:30 B-ALL: Updated practices (ÀÎÁ¦ÀÇ´ë ÀÓ¼º³²)

10:30-11:00 T-ALL: Updated practices (¾ÆÁÖÀÇ´ë ÃÖÀ±¼®)

11:00-11:30 Pathophysiology and biomarkers in ALL (¿ï»êÀÇ´ë ±è¹Ì¿µ)

11:30-12:00 Novel therapeutics in ALL (including preclinical) (°è¸íÀÇ´ë Çã¹ÌÈ­)

12:00-13:00: Lunch

Session 2: Hot topics in ALL (ºÎ»êÀÇ´ë ½ÅÈ£Áø)

13:00-14:00 Newest technology in T-cell engineering for lymphoid malignancy

(Çѱ¹°úÇбâ¼ú¿ø ±èÂùÇõ)

14:00-14:30 Insights on minimal residual disease measurement (°¡Å縯ÀÇ´ë ¾È¾Æ¸®)

14:30-15:00 MRD based ALL treatment (¼­¿ïÀÇ´ë °í¿µÀÏ)

15:00-15:10 Break

Session3: KALLWP Àӻ󿬱¸Á¦¾È (¼­¿ïÀÇ´ë °í¿µÀÏ)

15:10-16:00: Current status and new proposals

 

‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒‒

 

»çÀüµî·Ï: http://naver.me/FaZkZe1h ·Î »çÀüµî·Ï ºÎŹµå¸³´Ï´Ù.

¿¬±¸Á¦¾È ¸ÞÀÏÁÖ¼Ò: kay9801@naver.com, Àû±ØÀûÀÎ ¿¬±¸ Á¦¾È ºÎŹµå¸³´Ï´Ù.